# STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

> **NCT06626256** · PHASE1 · WITHDRAWN · sponsor: **City of Hope Medical Center**

## Conditions studied

- Locally Advanced Cervical Carcinoma
- Locally Advanced Colorectal Carcinoma
- Locally Advanced Malignant Solid Neoplasm
- Locally Advanced Melanoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Locally Advanced Renal Cell Carcinoma
- Metastatic Cervical Carcinoma
- Metastatic Colorectal Carcinoma
- Metastatic Malignant Solid Neoplasm
- Metastatic Melanoma
- Metastatic Pancreatic Ductal Adenocarcinoma
- Metastatic Renal Cell Carcinoma
- Stage II Pancreatic Cancer AJCC v8
- Stage III Cervical Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
- Stage III Pancreatic Cancer AJCC v8
- Stage III Renal Cell Cancer AJCC v8
- Stage IV Cervical Cancer AJCC v8
- Stage IV Colorectal Cancer AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
- Stage IV Renal Cell Cancer AJCC v8
- Unresectable Cervical Carcinoma
- Unresectable Colorectal Carcinoma
- Unresectable Malignant Solid Neoplasm
- Unresectable Melanoma
- Unresectable Pancreatic Ductal Adenocarcinoma
- Unresectable Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** Aldesleukin
- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Excisional Biopsy
- **DRUG:** Fludarabine
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Standard Treatment
- **BIOLOGICAL:** Therapeutic Tumor Infiltrating Lymphocytes

## Key facts

- **NCT ID:** NCT06626256
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12-05
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no resource
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06626256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06626256, "STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06626256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*